Corporate Profile
Sana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients. We share a vision of repairing and controlling genes, replacing missing or damaged cells, and making our therapies broadly available to patients. We are working together to create an enduring company that changes how the world treats disease. Sana has operations in Seattle, Cambridge, and South San Francisco.
Data Provided by Refinitiv. Minimum 15 minutes delayed.
News Releases
Aug 30, 2023
Aug 03, 2023
Jun 16, 2023
Events
Sep 12, 2023 at 1:35 PM EDT
Sep 11, 2023 at 10:00 AM EDT
Sep 7, 2023 at 2:15 PM EDT
SEC Filings
| Filing date | Description | Form |
|---|---|---|
| D | ||
| D | ||
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy |
DRS |